Wayne A.I. Frederick Sells 3,000 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) Director Wayne A.I. Frederick sold 3,000 shares of the business’s stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $45.54, for a total value of $136,620.00. Following the completion of the sale, the director now owns 26,514 shares of the company’s stock, valued at $1,207,447.56. This trade represents a 10.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Tempus AI Trading Up 5.7 %

Shares of NASDAQ:TEM traded up $2.67 during trading on Wednesday, reaching $49.89. 8,405,862 shares of the company’s stock traded hands, compared to its average volume of 5,283,473. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The company has a 50 day moving average of $58.64 and a 200-day moving average of $51.56.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on TEM shares. TD Cowen reissued a “buy” rating and issued a $74.00 price target (up from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Guggenheim reiterated a “buy” rating on shares of Tempus AI in a research report on Tuesday, February 25th. Wolfe Research cut Tempus AI from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 26th. William Blair reiterated a “market perform” rating on shares of Tempus AI in a report on Tuesday, February 25th. Finally, Morgan Stanley boosted their target price on shares of Tempus AI from $50.00 to $60.00 and gave the stock an “overweight” rating in a research note on Thursday, March 6th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $61.18.

Institutional Trading of Tempus AI

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Wells Fargo & Company MN increased its position in shares of Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock worth $80,000 after acquiring an additional 278 shares in the last quarter. Geode Capital Management LLC increased its position in Tempus AI by 0.4% during the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock worth $7,537,000 after buying an additional 539 shares during the last quarter. Operose Advisors LLC bought a new position in shares of Tempus AI in the 4th quarter valued at approximately $25,000. Prestige Wealth Management Group LLC lifted its stake in shares of Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after buying an additional 965 shares during the last quarter. Finally, Farther Finance Advisors LLC acquired a new stake in shares of Tempus AI in the fourth quarter valued at about $34,000. 24.22% of the stock is currently owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.